GLP-1 agonist treatment: implications for diabetic retinopathy screening
- PMID: 21906831
- DOI: 10.1016/j.diabres.2011.08.017
GLP-1 agonist treatment: implications for diabetic retinopathy screening
Abstract
Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical